Product Information
VRAYLAR 6 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $50.7778 per EA under NDC 61874016030. Its NADAC has been published 514 times since Oct 19, 2016.
FDA first approved this application on Sep 17, 2015.
Strength
6 mg/1
Manufacturer
Allergan, Inc.NDC
61874016030
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARIPRAZINEApproval Type
New Drug (NDA)
FDA Application
NDA204370FDA Approved
9/17/2015
On Market Since
9/17/2015
Pharmacological Classes
Price Statistics
The NADAC for VRAYLAR 6 MG CAPSULE has been published 514 times since Oct 19, 2016, and over the history we have for it it has risen 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.7778 per EA |
|---|---|
| All-time high | $50.9144 (May 13, 2026) |
| All-time low | $32.0496 (Mar 22, 2017) |
| 52-week high | $50.9144 |
| 52-week low | $48.4774 |
| Median price | $40.5178 |
| Average price | $41.6484 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 514 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cariprazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VRAYLAR 6 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VRAYLAR 6 MG CAPSULE, manufactured by Allergan, Inc., is $50.7778 per EA (NDC 61874016030), effective Aug 19, 2026.
How has the price of VRAYLAR 6 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VRAYLAR 6 MG CAPSULE has risen 57.4%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for VRAYLAR 6 MG CAPSULE?
Since Oct 19, 2016, the NADAC for VRAYLAR 6 MG CAPSULE has ranged from a low of $32.0496 (Mar 22, 2017) to a high of $50.9144 (May 13, 2026), with a median of $40.5178 per EA.
Are there cheaper alternatives to VRAYLAR 6 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of VRAYLAR 6 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VRAYLAR 6 MG CAPSULE?
VRAYLAR 6 MG CAPSULE (NDC 61874016030) is labeled by Allergan, Inc., and CMS classifies it as a brand product.